Document:

EX-10.1

 Exhibit 10.1 

SUBSCRIPTION AGREEMENT 

August 11, 2022 
 GreenLight
Biosciences Holdings, PBC, a Delaware corporation (formerly known as Environmental Impact Acquisition Corp.) (the “Company”), is seeking commitments from interested investors to purchase shares of the Company’s Common Stock,
par value $0.0001 per share (the “Common Stock”), for a purchase price of $[______]1 per share (the “Purchase Price per Share” and the aggregate of such Purchase
Price per Share for all Shares (as defined below) being referred to herein as the “Purchase Price”), in a private placement to be conducted by the Company (the “Offering”). 

On the date set forth on the signature page of this subscription agreement (this “Subscription Agreement”), the Company is
entering into subscription agreements (the “Other Subscription Agreements” and together with the Subscription Agreement, the “Subscription Agreements”) with certain other subscribers (the “Other
Subscribers” and together with the undersigned, the “Subscribers”), which are on substantially the same terms as the terms of this Subscription Agreement, pursuant to which the Subscribers, severally and not jointly, have
agreed to purchase on the closing date of the Offering, inclusive of the shares of Common Stock to be purchased by the undersigned, an aggregate amount of [______] shares of Common Stock at the Purchase Price per Share. In connection therewith, the
undersigned subscriber (the “Subscriber”) and the Company agree as follows: 
 1. Subscription.
Subject to the terms and conditions hereof, at the Closing (as defined below), the Subscriber hereby subscribes for and agrees to purchase from the Company, and the Company hereby agrees to issue and sell to the Subscriber, such number of shares of
Common Stock as is set forth on the signature page of this Subscription Agreement (the “Shares”) at the Purchase Price per Share and on the terms provided for herein. 

2. Closing; Delivery of Shares. 

a. The closing of the sale of Shares contemplated hereby (the “Closing”, and the date that the Closing actually occurs, the
“Closing Date”) shall occur on the date hereof; provided that all of the conditions set forth in Section 3 herein have been satisfied. 

b. If the Closing Date does not occur on the date hereof, the Company shall provide written notice (which may be via email) to the Subscriber
(the “Closing Notice”) that the Company reasonably expects all conditions set forth in Section 3 herein to have been satisfied on or before a date specified in the notice (the “Scheduled Closing Date”) that is
not less than two (2) business days from the date on which the Closing Notice is delivered to the Subscriber, which Closing Notice shall contain (i) such Scheduled Closing Date and (ii) the wire instructions for the payment of the
Subscriber’s Purchase Price for the Shares) to an account specified by the Company. Further, subject to the satisfaction or waiver of the conditions set forth in this Section 2 and Section 3, the Subscriber shall deliver to the
Company, prior to 10:00 a.m. (Eastern Time) on the Scheduled Closing Date, the Purchase Price for the Shares by wire transfer of United States dollars in immediately available funds to the account set forth in such wire instructions. On the Closing
Date, the Company shall deliver to the Subscriber (1) the Shares in book entry form, free and clear of any liens or other restrictions whatsoever (other than those arising under state or federal securities laws), in the name of the Subscriber
(or its nominee in accordance with its delivery instructions) or to a custodian designated by the Subscriber, as applicable, and (2) a copy of the records of the Company or its transfer agent showing the Subscriber as the owner of the Shares on
and as of the Closing Date (the “Subscriber’s Deliveries”). 
 3. Closing Conditions. In addition
to the conditions set forth in Section 2: 
 a. The Closing is also subject to the satisfaction or valid waiver by each party of the
conditions that, on the Closing Date: 
  

	 	i.	 no suspension of the qualification of the Shares for offering or sale or trading in any jurisdiction, or
initiation or threatening of any proceedings for any of such purposes, shall have occurred; and 

  

	1 	 To insert closing price on Wednesday, August 10, 2022 

	 	ii.	 no governmental authority of competent jurisdiction shall have rendered, issued, promulgated, enforced, enacted
or entered any judgment, order, law, rule or regulation (whether temporary, preliminary or permanent) which is then in effect and which then makes the consummation of the transactions contemplated hereby illegal or then restrains or prohibits the
consummation of the transactions contemplated hereby. 

 b. The obligations of the Company to consummate the Closing are
also subject to the satisfaction or valid waiver by the Company of the additional conditions that, on the Closing Date: 
  

	 	i.	 all representations and warranties of the Subscriber contained in this Subscription Agreement shall be true and
correct in all material respects (other than representations and warranties that are qualified as to materiality, which representations and warranties shall be true in all respects) at and as of the Closing Date (except for representations and
warranties made as of a specific date, which shall be true and correct in all material respects (other than representations and warranties that are qualified as to materiality, which representations and warranties shall be true in all respects) as
of such date); and 

  

	 	ii.	 the Subscriber shall have performed, satisfied and complied in all material respects with all covenants,
agreements and conditions required by this Subscription Agreement to be performed, satisfied or complied with by it at or prior to Closing. 

c. The obligations of the Subscriber to consummate the Closing are also subject to the satisfaction or valid waiver by the Subscriber of the
additional conditions that, on the Closing Date: 
  

	 	i.	 all representations and warranties of the Company contained in this Subscription Agreement shall be true and
correct in all material respects (other than representations and warranties that are qualified as to materiality or Material Adverse Effect (as defined herein), which representations and warranties shall be true in all respects) at and as of the
Closing Date (except for representations and warranties made as of a specific date, which shall be true and correct in all material respects (other than representations and warranties that are qualified as to materiality or Material Adverse Effect,
which representations and warranties shall be true in all respects) as of such date); and 

  

	 	ii.	 the Company shall have performed, satisfied and complied in all material respects with all covenants,
agreements and conditions required by this Subscription Agreement to be performed, satisfied or complied with by it at or prior to Closing. 

d. Prior to or at the Closing, the Subscriber shall deliver to the Company a duly completed and executed Internal Revenue Service Form W-9 or appropriate Form W-8. 
 e. At and from the Closing, the
Company and the Subscriber shall execute and deliver such additional documents and take such additional actions as the parties reasonably may deem to be practical and necessary in order to consummate the transactions contemplated in this
Subscription Agreement. 
 4. Company Representations and Warranties. The Company represents and warrants to the
Subscriber that: 
 a. The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of
Delaware. The Company has the corporate power and authority to own, lease and operate its properties and conduct its business as presently conducted and to enter into, deliver and perform its obligations under this Subscription Agreement. 

b. The Shares have been duly authorized and, when issued and delivered to the Subscriber against full payment therefor in accordance with the
terms of this Subscription Agreement, the Shares will be (i) validly issued, fully paid and non-assessable and will not have been issued in violation of or subject to any preemptive or similar rights, and
(ii) free and clear of any liens or other restrictions whatsoever (other than those arising under state or federal securities laws). 

 c. This Subscription Agreement has been duly authorized, executed and delivered by the
Company and is enforceable against the Company in accordance with its terms, except as may be limited or otherwise affected by (i) bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other laws relating to or affecting
the rights of creditors generally, and (ii) principles of equity, whether considered at law or equity. 
 d. The execution, delivery
and performance of this Subscription Agreement, including the issuance and sale of the Shares and the consummation of the transactions contemplated hereby, will not conflict with or result in a material breach or material violation of any of the
terms or provisions of, or constitute a material default under, or result in the creation or imposition of any lien, charge or encumbrance upon any of the property or assets of the Company or any of its subsidiaries pursuant to the terms of
(i) any indenture, mortgage, deed of trust, loan agreement, license, lease or any other agreement or instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which
any of the property or assets of the Company is subject, which would reasonably be expected to have a material adverse effect on the business, prospects, properties, assets, liabilities, operations, condition (including financial condition),
stockholders’ equity or results of operations of the Company or materially affect the validity of the Shares or the legal authority or ability of the Company to perform in all material respects its obligations under the terms of this
Subscription Agreement (a “Material Adverse Effect”); (ii) the provisions of the organizational documents of the Company; or (iii) any statute or any judgment, order, rule or regulation of any court or governmental agency or
body (including the NASDAQ Global Market), domestic or foreign, having jurisdiction over the Company or any of its properties that would have a Material Adverse Effect or materially affect the validity of the Shares or the legal authority or ability
of the Company to perform in all material respects its obligations under the terms of this Subscription Agreement. 
 e. Assuming the
accuracy of the representations and warranties of the Subscriber, the Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state,
local or other governmental authority, self-regulatory organization or other person in connection with the execution, delivery and performance by the Company of this Subscription Agreement (including, without limitation, the issuance of the Shares),
other than (i) any required filing of a Notice of Exempt Offering of Securities on Form D with U.S. Securities and Exchange Commission (the “SEC”) under Regulation D of the Securities Act of 1933, as amended (the
“Securities Act”), (ii) the filing with the SEC of the Registration Statement (as defined below), (iii) the filings required by applicable state or federal securities laws, (iv) the filings required in accordance with
Section 10, (v) any filings or notices required by the Nasdaq Global Market (“NASDAQ”), and (vi) any consent, waiver, authorization or order of, notice to, or filing or registration, the failure of which to obtain would
not be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect. The Company is not required to obtain stockholder approval with respect to the Offering. 

f. As of the date of this Subscription Agreement, the authorized capital stock of the Company consists of (i) 500,000,000 shares of Common
Stock and (ii) 10,000,000 shares of preferred stock, par value of $0.0001 per share (the “Preferred Stock”). As of the date of this Subscription Agreement, (A) [123,199,202] shares of Common Stock are issued and outstanding, (B)
10,350,00 public warrants to purchase Common Stock are issued and outstanding, (C) 2,062,500 private placement warrants to purchase Common Stock are issued and outstanding and (D) no Preferred Stock is issued and outstanding. All
(1) issued and outstanding shares of Common Stock have been duly authorized and validly issued, are fully paid and are non-assessable and are not subject to preemptive rights and (2) outstanding
warrants have been duly authorized and validly issued and are not subject to preemptive rights. Except as set forth above and pursuant to the Other Subscription Agreements or in the SEC Documents (as defined below), as of the date hereof, there are
no outstanding options, warrants or other rights to subscribe for, purchase or acquire from the Company shares of Common Stock or other equity interests in the Company, or securities convertible into or exchangeable or exercisable for such equity
interests. As of the date hereof, other than as set for the in the SEC Documents, the Company has no subsidiaries and does not own, directly or indirectly, interests or investments (whether equity or debt) in any person, whether incorporated or
unincorporated. As of the date hereof, other than as set forth in the SEC Documents, there are no shareholder agreements, voting trusts or other agreements or understandings to which the Company is a party or by which it is bound relating to the
voting of any securities of the Company. There are no securities or instruments issued by or to which the Company is a party containing anti-dilution or similar provisions that will be triggered by the issuance of (i) the Shares or
(ii) the shares to be issued pursuant to any Other Subscription Agreement, in each case, that have not been or will not be validly waived on or prior to the Closing Date. 

 g. The issued and outstanding shares of Common Stock are registered pursuant to
Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and are listed for trading on NASDAQ under the symbol “GRNA.” There is no suit, action, proceeding or investigation pending or, to
the knowledge of the Company, threatened against the Company by NASDAQ or the SEC with respect to any intention by such entity to deregister the Common Stock or prohibit or terminate the listing of the Common Stock on NASDAQ. 

h. Other than the Other Subscription Agreements, the Company has not entered into any side letter or similar agreement with any Other
Subscriber or any other investor in connection with such Other Subscriber’s or investor’s direct or indirect investment in the Company. No Other Subscription Agreement contains a different Purchase Price Per Share or includes other terms
and conditions that are materially more advantageous to any such Other Subscriber than the Subscriber hereunder, and such Other Subscription Agreements have not been amended or modified in any material respect following the date of this Subscription
Agreement. 
 i. The Company has made available to the Subscriber (including via the SEC’s EDGAR system) a true, correct and complete
copy of each form, report, statement, schedule, prospectus, proxy, registration statement and other documents filed by the Company with the SEC prior to the date of this Subscription Agreement (the “SEC Documents”). None of the SEC
Documents filed under the Exchange Act contained, when filed and as amended to the date hereof, any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements
made therein, in the light of the circumstances under which they were made, not misleading, and such SEC Documents complied in all material respects with the requirements of the Exchange Act and the rules and regulations of the SEC promulgated
thereunder. The Company has timely filed each report, statement, schedule, prospectus, and registration statement that the Company was required to file with the SEC since its initial registration of the Common Stock with the SEC. As of the date
hereof, there are no material outstanding or unresolved comments in comment letters from the Staff of the SEC with respect to any of the SEC Documents. 

j. Except for such matters as have not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect, there is no (i) action, suit, claim or other proceeding, in each case by or before any governmental authority pending, or, to the knowledge of the Company, threatened against the Company or (ii) judgment, decree, injunction, ruling
or order of any governmental entity outstanding against the Company. 
 k. The Company is in compliance with all applicable laws, except
where such non-compliance would not reasonably be expected to have a Material Adverse Effect. The Company has not received any written communication from a governmental entity that alleges that the Company is
not in compliance with or is in default or violation of any applicable law, except where such non-compliance, default or violation would not, individually or in the aggregate, be reasonably expected to have a
Material Adverse Effect. 
 l. The Company has not entered into any agreement or arrangement entitling any agent, broker, investment banker,
financial advisor or other person to any broker’s or finder’s fee or any other commission or similar fee in connection with the transactions contemplated by this Subscription Agreement for which the Subscriber could become liable. Other
than Credit Suisse Securities (USA) LLC (“Credit Suisse”) and Robert W. Baird & Co. Incorporated (“Baird” and together with Credit Suisse, the “Placement Agents”), the Company is not aware
of any person that has been or will be paid (directly or indirectly) remuneration for acting as a placement agent in connection with the sale of any shares of Common Stock in the Offering. 

m. The Company is not, and immediately after receipt of payment for the Shares, will not be, an “investment company” within the
meaning of the Investment Company Act of 1940, as amended. 
 n. Assuming the accuracy of the Subscriber’s representations and
warranties set forth in Section 5, in connection with the offer, sale and delivery of the Shares in the manner contemplated by this Subscription Agreement, it is not necessary to register the Shares under the Securities
Act. The Shares (i) were not offered by any form of general solicitation or general advertising and (ii) are not being offered in a manner involving a public offering under, or in a distribution in violation of, the Securities Act or any
state securities laws. 

 o. If applicable, the Subscriber shall comply promptly but in no event later than ten
(10) business days after the date hereof with all applicable notification and reporting requirements pursuant to the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the “HSR Act”). If applicable, Subscriber shall use its
reasonable best efforts to furnish to the Company, as promptly as reasonably practicable, all information required for any notification or filing to be made pursuant to the HSR Act in connection with the Offering. If applicable, Subscriber shall
request early termination of all applicable waiting periods under the HSR Act with respect to the Offering and shall use its reasonable best efforts to (i) cooperate in good faith with the relevant authorities; (ii) substantially comply
with any information or document requests; and (iii) obtain the termination or expiration of all waiting periods under the HSR Act, in each case, in connection with the Offering. 

p. No “bad actor” disqualifying event described in Rule 506(d)(1)(i)-(viii) of the Securities Act (a “Disqualification
Event”) is applicable to the Company, except for a Disqualification Event as to which Rule 506(d)(2)(ii–)-(iv) or (d)(3) of the Securities Act is applicable. 

q. The Company owns or possesses adequate rights or licenses to use all trademarks, trade names, service marks, service mark registrations,
service names, patents, patent rights, copyrights, original works of authorship, inventions, licenses, approvals, governmental authorizations, trade secrets and other intellectual property rights and all applications and registrations therefor
(“Intellectual Property Rights”) necessary to conduct its business as now conducted. None of the Company’s Intellectual Property Rights have expired, terminated or been abandoned, or are expected to expire, terminate or be abandoned,
within three years from the date of this Agreement. The Company has no knowledge of any infringement by the Company of Intellectual Property Rights of others. There is no claim, action or proceeding being made or brought, or to the knowledge of the
Company, being threatened, against the Company regarding its Intellectual Property Rights. The Company is not aware of any facts or circumstances which might give rise to any of the foregoing infringements or claims, actions or proceedings. The
Company has taken reasonable security measures to protect the secrecy, confidentiality and value of all of its Intellectual Property Rights that have been developed by the Company. 

r. The studies, tests and preclinical and clinical trials conducted by or, to the Company’s knowledge, on behalf of the Company were and,
if still ongoing, are being conducted in all material respects in accordance with experimental protocols, procedures and controls pursuant to accepted professional scientific standards and all applicable laws, including, without limitation, the
Federal Food, Drug and Cosmetic Act and the rules and regulations promulgated thereunder; the descriptions of the results of such studies, tests and trials contained in the SEC Documents are, to the Company’s knowledge, accurate and complete in
all material respects and fairly present the data derived from such studies, tests and trials; except to the extent disclosed in the SEC Documents, the Company is not aware of any studies, tests or trials, the results of which the Company believes
reasonably call into question the study, test, or trial results described or referred to in the SEC Documents when viewed in the context in which such results are described and the clinical state of development; and, except to the extent disclosed
in the SEC Documents, the Company has not received any notices or correspondence from the FDA or any governmental entity requiring the termination or suspension of any studies, tests or preclinical or clinical trials conducted by or on behalf of the
Company, other than ordinary course communications with respect to modifications in connection with the design and implementation of such trials. 

s. The Company understands that the foregoing representations and warranties shall be deemed material to and have been relied upon by the
Subscriber. 
 5. Subscriber Representations, Warranties and Covenants. The Subscriber represents and warrants to the
Company that: 
 a. At the time the Subscriber was offered the Shares, it was, and as of the date hereof, the Subscriber is (i) a
“qualified institutional buyer” (as defined in Rule 144A under the Securities Act) or an institutional “accredited investor” (within the meaning of Rule 501(a) of Regulation D under the Securities Act) satisfying the applicable
requirements set forth on Exhibit A hereto, and accordingly, understands that the offering meets the exemptions from filing under FINRA Rule 5123(b)(1)(C) or (J), and (ii) is acquiring the Shares only for its own account and (iii) not for
the account of others, and not on behalf of any other account or person or with a view to, or for offer or sale in connection with, any distribution thereof in violation of the Securities Act. The Subscriber is not an entity formed for the specific
purpose of acquiring the Shares. 

 b. The Subscriber understands that the Shares are being offered in a transaction not
involving any public offering within the meaning of the Securities Act and that the Shares delivered at the Closing have not been registered under the Securities Act. The Subscriber understands that the Shares may not be resold, transferred, pledged
or otherwise disposed of by the Subscriber absent an effective registration statement under the Securities Act except (i) to the Company or a subsidiary thereof, (ii) to non-U.S. persons pursuant to
offers and sales that occur outside the United States within the meaning of Regulation S under the Securities Act or (iii) pursuant to another applicable exemption from the registration requirements of the Securities Act, and in each of cases
(i) and (iii) in accordance with any applicable securities laws of the states and other jurisdictions of the United States, and that any certificates (if any) or any book-entry shares representing the Shares delivered at the Closing shall
contain a legend or restrictive notation to such effect, as a result, the Subscriber may not be able to readily offer, resell, transfer, pledge or otherwise dispose of the Shares and may be required to bear the financial risk of an investment in the
Shares for an indefinite period of time. The Subscriber acknowledges that the Shares will not be eligible for resale pursuant to Rule 144A promulgated under the Securities Act. The Subscriber further acknowledges that the Shares will not be eligible
for resale pursuant to Rule 144 promulgated under the Securities Act, until, at the earliest, February 7, 2023. The Subscriber understands that it has been advised to consult legal counsel prior to making any offer, resale, pledge or transfer
of any of the Shares. 
 c. The Subscriber understands and agrees that the Subscriber is purchasing Shares directly from the Company. The
Subscriber further acknowledges that there have been no representations, warranties, covenants and agreements made to the Subscriber by the Company, or any of its officers or directors, expressly (other than those representations, warranties,
covenants and agreements included in this Subscription Agreement) or by implication. 
 d. The Subscriber’s acquisition and holding of
the Shares will not constitute or result in a non-exempt prohibited transaction under Section 406 of the Employee Retirement Income Security Act of 1974, as amended, Section 4975 of the Internal
Revenue Code of 1986, as amended, or any applicable similar law. 
 e. The Subscriber acknowledges and agrees that the Subscriber has
received such information as the Subscriber deems necessary in order to make an investment decision with respect to the Shares. Without limiting the generality of the foregoing, the Subscriber acknowledges that it has received (or in the case of
documents filed with the SEC, had access to) the following items (collectively, the “Disclosure Documents”): (i) the SEC Documents and (ii) the investor presentation by the Company, a copy of which will be furnished by the
Company to the SEC. The Subscriber represents and agrees that the Subscriber and the Subscriber’s professional advisor(s), if any, have had the full opportunity to ask the Company’s management questions, receive such answers and obtain
such information as the Subscriber and such Subscriber’s professional advisor(s), if any, have deemed necessary to make an investment decision with respect to the Shares. 

f. The Subscriber became aware of this Offering of the Shares solely by means of direct contact between the Subscriber and the Company, the
Placement Agents or a representative of the Company or the Placement Agents, and the Shares were offered to the Subscriber solely by direct contact between the Subscriber and the Company, the Placement Agents or a representative of the Company or
the Placement Agents. The Subscriber did not become aware of this offering of the Shares, nor were the Shares offered to the Subscriber, by any other means. The Subscriber acknowledges that the Company represents and warrants that the Shares
(i) were not offered by any form of general solicitation or general advertising and (ii) are not being offered in a manner involving a public offering under, or in a distribution in violation of, the Securities Act, or any state securities
laws. The Subscriber acknowledges that the Subscriber shall be responsible for any of the Subscriber’s tax liabilities that may arise as a result of the transactions contemplated by this Subscription Agreement, and that neither the Company nor
the Target has provided any tax advice or any other representation or guarantee regarding the tax consequences of the transactions contemplated by the Subscription Agreement. 

g. The Subscriber acknowledges that it is aware that there are substantial risks incident to the purchase and ownership of the Shares,
including those set forth in the Disclosure Documents and in the Company’s filings with the SEC. The Subscriber is able to fend for itself in the transactions contemplated herein and has such knowledge and experience in financial and business
matters as to be capable of evaluating the merits and risks of an investment in the Shares, and the Subscriber has sought such accounting, legal and tax advice as the Subscriber has considered necessary to make an informed investment decision. 

 h. Alone, or together with any professional advisor(s), the Subscriber has adequately
analyzed and fully considered the risks of an investment in the Shares and determined that the Shares are a suitable investment for the Subscriber and that the Subscriber is able at this time and in the foreseeable future to bear the economic risk
of a total loss of the Subscriber’s investment in the Company. The Subscriber acknowledges specifically that a possibility of total loss exists. The Subscriber has exercised independent judgment in evaluating its participation in the
Subscription, and accordingly, the Subscriber understands that the offering meets (i) the exemptions from filing under FINRA Rule 5123(b)(1)(A) and (ii) the institutional customer exemption under FINRA Rule 2111(b). 

i. In making its decision to purchase the Shares, the Subscriber has relied solely upon independent investigation made by the Subscriber and
the representations and warranties of the Company set forth herein. The Subscriber has determined based on such independent investigation and any professional advice as it deems appropriate that its purchase of the Shares and participation in the
transactions contemplated by this Agreement (i) are fully consistent with its financial needs, objectives and condition, (ii) comply and are fully consistent with all investment policies, guidelines and other restrictions applicable to it,
(iii) have been duly authorized and approved by all necessary action, and (iv) do not and will not violate or constitute a default under its charter, by-laws or other constituent document or under
any law, rule, regulation, agreement or other obligation by which it is bound. The Subscriber represents and agrees that the Subscriber and the Subscriber’s professional advisor(s), if any, have (i) had the full opportunity to ask such
questions, receive such answers and obtain such information as the Subscriber and such undersigned’s professional advisor(s), if any, have deemed necessary to make an investment decision with respect to the Shares and (ii) conducted and
completed independent due diligence with respect to the Subscription and the Shares. Without limiting the generality of the foregoing, the Subscriber has not relied on any statements or other information provided by the Placement Agents, the
Company, any of their respective affiliates or any of such person’s or its affiliates’ control persons, officers, directors, employees or other representatives, legal counsel, financial advisors, accountants or agents concerning the
Company, the Target or the Shares or the offer and sale of the Shares, other than the representations and warranties of the Company contained in Section 4 of this Subscription Agreement, in making its investment or decision to invest in the
Company. Subscriber acknowledges and agrees that the Placement Agents have not, acting in their role as placement agents to the Company, provided Subscriber with any information or advice with respect to the Shares nor is such information or advice
necessary or desired. The Placement Agents, acting in their role as placement agents to the Company, have not made and are not making any representation as to the Company or Target or the quality or value of the Shares and the Placement Agents,
acting in their role as placement agents to the Company, may have acquired non-public information with respect to the Company or Target which Subscriber agrees need not be provided to it. The Placement Agents,
acting in their role as placement agents to the Company, have no responsibility with respect to the completeness or accuracy of any information or materials furnished to such Subscriber in connection with the transactions contemplated hereby. 

j. The Subscriber understands and agrees that no federal or state agency has passed upon or endorsed the merits of the Offering or made any
findings or determination as to the fairness of this investment or the accuracy or adequacy of the Company’s filings with the SEC. 

k. The Subscriber has been duly formed or incorporated and is validly existing in good standing under the laws of its jurisdiction of
incorporation or formation. 
 l. The execution, delivery and performance by the Subscriber of this Subscription Agreement are within the
powers of the Subscriber, have been duly authorized and will not constitute or result in a breach or default under or conflict with any federal or state statute, rule or regulation applicable to the Subscriber, any order, ruling or regulation of any
court or other tribunal or of any governmental commission or agency, or any agreement or other undertaking, to which the Subscriber is a party or by which the Subscriber is bound, any indenture, mortgage, deed of trust, loan agreement, lease,
license or other agreement or instrument to which the Subscriber is a party or by which the Subscriber is bound or to which any of the property or assets of the Subscriber is subject, and, if the Subscriber is not an individual, will not violate any
provisions of the Subscriber’s charter documents, including its incorporation or formation papers, bylaws, indenture of trust or partnership or operating agreement, as may be applicable. The signature on this Subscription Agreement is genuine,
and the signatory, if the Subscriber is an individual, has legal competence and capacity to execute the same or, if the Subscriber is not an individual the signatory has been duly authorized to execute the same, and this Subscription Agreement
constitutes a legal, valid and binding obligation of the Subscriber, enforceable against the Subscriber in accordance with its terms. 

 m. Neither the due diligence investigation conducted by the Subscriber in connection with
making its decision to acquire the Shares nor any representations and warranties made by the Subscriber herein shall modify, amend or affect the Subscriber’s right to rely on the truth, accuracy and completeness of the Company’s
representations and warranties contained herein. 
 n. The Subscriber is not (i) a person or entity named on the List of Specially
Designated Nationals and Blocked Persons administered by the U.S. Treasury Department’s Office of Foreign Assets Control (“OFAC”) or in any Executive Order issued by the President of the United States and administered by OFAC
(“OFAC List”), or a person or entity prohibited by any OFAC sanctions program, (ii) a Designated National as defined in the Cuban Assets Control Regulations, 31 C.F.R. Part 515, or (iii) a
non-U.S. shell bank or providing banking services indirectly to a non-U.S. shell bank (collectively, a “Prohibited Investor”). The Subscriber agrees to
provide law enforcement agencies, if requested thereby, such records as required by applicable law, provided that the Subscriber is permitted to do so under applicable law. If the Subscriber is a financial institution subject to the Bank
Secrecy Act (31 U.S.C. Section 5311 et seq.), as amended by the USA PATRIOT Act of 2001, and its implementing regulations (collectively, the “BSA/PATRIOT Act”), the Subscriber maintains policies and procedures reasonably
designed to comply with applicable obligations under the BSA/PATRIOT Act. To the extent required, it maintains policies and procedures reasonably designed for the screening of its investors against the OFAC sanctions programs, including the OFAC
List. To the extent required, it maintains policies and procedures reasonably designed to ensure that the funds held by the Subscriber and used to purchase the Shares were legally derived. 

o. The Subscriber does not have, as of the date hereof, any “put equivalent position” as such term is defined in Rule 16a-1 under the Exchange Act, any “short sales” as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act, and any type of direct or indirect stock pledges (other than pledges in the
ordinary course of business as part of prime brokerage arrangements), forward sale contracts, options, puts, calls, swaps and similar arrangements (including on a total return basis), and or other short sale positions, whether through a broker
dealer or otherwise, with respect to the securities of the Company (collectively, “Short Sales”). Notwithstanding the foregoing, in the case (i) other entities under common management with the Subscriber that have no knowledge
of this Subscription Agreement or of the Subscriber’s participation in the Offering (including the Subscriber’s affiliates) or (ii) the Subscriber is a multi-managed investment vehicle whereby separate portfolio managers manage
separate portions of such Subscriber’s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Subscriber’s assets, then, in each case, the
foregoing representation shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Shares covered by this Agreement. The Company acknowledges and agrees that,
notwithstanding anything herein to the contrary, the Shares may be pledged by Subscriber in connection with a bona fide margin agreement, provided that such pledge shall be (1) pursuant to an available exemption from the registration
requirements of the Securities Act or (2) pursuant to, and in accordance with, a registration statement that is effective under the Securities Act at the time of such pledge, and Subscriber effecting a pledge of the Shares shall not be required
to provide the Company with any notice thereof. 
 p. If the Subscriber is an employee benefit plan that is subject to Title I of ERISA, a
plan, an individual retirement account or other arrangement that is subject to section 4975 of the Code or an employee benefit plan that is a governmental plan (as defined in section 3(32) of ERISA), a church plan (as defined in section 3(33) of
ERISA), a non-U.S. plan (as described in section 4(b)(4) of ERISA) or other plan that is not subject to the foregoing but may be subject to provisions under any other federal, state, local, non-U.S. or other laws or regulations that are similar to such provisions of ERISA or the Internal Revenue Code of 1986, as amended, or an entity whose underlying assets are considered to include “plan
assets” of any such plan, account or arrangement (each, a “Plan”) subject to the fiduciary or prohibited transaction provisions of ERISA or section 4975 of the Code, the Subscriber represents and warrants that neither the
Company, nor any of its respective affiliates (the “Transaction Parties”) has acted as the Plan’s fiduciary, or has been relied on for advice, with respect to its decision to acquire and hold the Shares, and none of the
Transaction Parties shall at any time be relied upon as the Plan’s fiduciary with respect to any decision to acquire, continue to hold or transfer the Shares. 

 q. At the Closing, the Subscriber will have sufficient funds to pay the Purchase Price
pursuant to Section 2(b) above. 
 r. The Subscriber acknowledges its obligations under applicable securities laws with respect to the
treatment of non-public information relating to the Company. 
 s. No disclosure or offering
document has been prepared by the Placement Agents in connection with the offer and sale of the Shares. The Placement Agents and each of their members, directors, officers, employees, representatives and controlling persons have made no independent
investigation with respect to the Company or the Shares or the accuracy, completeness or adequacy of any information supplied to the Subscriber by the Company. In connection with the issue and purchase of the Shares, the Placement Agents have not
acted as the Subscriber’s financial advisor or fiduciary. 
 6. Registration Rights. 

a. The Company agrees that, within forty-five (45) calendar days after the Closing Date (the “Filing Date”), the Company
will file with the SEC (at the Company’s sole cost and expense) a registration statement registering the resale of the Shares (the initial registration statement and any other registration statement that may be filed by the Company under this
Section 6, the “Registration Statement”), and the Company shall use its commercially reasonable efforts to have the Registration Statement declared effective as soon as practicable after the filing thereof but no later than the
earlier of (i) the 90th calendar day (or 120th calendar day if the SEC notifies the Company that it will “review” the Registration Statement) following the Closing Date and (ii) the 10th business day after the date the Company is
notified (orally or in writing, whichever is earlier) by the SEC that the Registration Statement will not be “reviewed” or will not be subject to further review (such earlier date, the “Effectiveness Date”). The Company
agrees that the Company will cause such Registration Statement or another registration statement (which may be a “shelf” registration statement) to remain effective until the earlier of (i) three (3) years from the date of
effectiveness of the initial Registration Statement, (ii) the date on which the Subscriber ceases to hold any Shares covered by such Registration Statement, or (iii) on the first date on which the Subscriber can sell all of its Shares
under Rule 144 of the Securities Act without restriction, including without limitation, any volume and manner of sale restrictions which may be applicable to affiliates under Rule 144 and without the requirement for the Company to be in compliance
with the current public information required under Rule 144(c)(1) (or Rule 144(i)(2), if applicable). The Subscriber agrees to disclose its beneficial ownership, as determined in accordance with Rule 13d-3 of
the Exchange Act, of the Shares to the Company upon request to assist the Company in making the determination described above. The Company’s obligations to include the Shares in the Registration Statement are contingent upon the Subscriber
furnishing in writing to the Company such information regarding the Subscriber, the securities of the Company held by the Subscriber and the intended method of disposition of the Shares as shall be reasonably requested by the Company to effect the
registration of the Shares, and shall execute such documents in connection with such registration as the Company may reasonably request that are customary of a selling stockholder in similar situations, provided that the Subscriber shall not
in connection with the foregoing be required to execute any lock-up or similar agreement or otherwise be subject to any contractual restriction on the ability to transfer the Shares. With respect to the
information to be provided by the Subscriber pursuant to this Section 6 or otherwise in connection with the Registration Statement, the Company shall request such information from the Subscriber at least ten (10) business days prior to the
anticipated filing date of the Registration Statement. Any failure by the Company to file the Registration Statement by the Filing Date or for the Registration Statement to be declared effective by the Effectiveness Date shall not otherwise relieve
the Company of its obligations to file or effect the Registration Statement as set forth in this Section 6. For purposes of this Section 6, “Shares” shall mean, as of any date of determination, the Shares and any other equity
security of the Company issued or issuable with respect to the Shares by way of share split, dividend, distribution, recapitalization, merger, exchange, replacement or similar event or otherwise. In no event shall Subscriber be identified as a
statutory underwriter in the Registration Statement unless requested by the Commission; provided that if the Commission requests that Subscriber be identified as a statutory underwriter in the Registration Statement, Subscriber will have an
opportunity to withdraw from the Registration Statement. 

 b. In the case of the registration, qualification, exemption or compliance effected by the
Company pursuant to this Subscription Agreement, the Company shall, upon reasonable request, inform the Subscriber as to the status of such registration, qualification, exemption and compliance. At its expense, the Company shall: 

 

	 	i.	 except for such times as the Company is permitted hereunder to suspend the use of the prospectus forming part
of a Registration Statement, use its commercially reasonable efforts to keep such registration, and any qualification, exemption or compliance under state securities laws which the Company determines to obtain, continuously effective with respect to
the Subscriber, and to keep the applicable Registration Statement or any subsequent shelf registration statement free of any material misstatements or omissions; 

 

	 	ii.	 advise the Subscriber within five (5) business days: 

 

	 	1.	 of the issuance by the SEC of any stop order suspending the effectiveness of any Registration Statement or the
initiation of any proceedings for such purpose; 

  

	 	2.	 of the receipt by the Company of any notification with respect to the suspension of the qualification of the
Shares included therein for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; and 

  

	 	3.	 subject to the provisions in this Subscription Agreement, of the occurrence of any event that requires the
making of any changes in any Registration Statement or prospectus included therein so that, as of such date, the statements therein are not misleading and do not omit to state a material fact required to be stated therein or necessary to make the
statements therein (in the case of a prospectus, in the light of the circumstances under which they were made) not misleading. 

Notwithstanding anything to the contrary set forth herein, the Company shall not, when so advising the Subscriber of such events listed
above, provide the Subscriber with any material, nonpublic information regarding the Company other than to the extent that providing notice to Subscriber of the occurrence of the events listed in (A) through (C) above constitutes material,
nonpublic information regarding the Company; 
  

	 	iii.	 use its commercially reasonable efforts to obtain the withdrawal of any order suspending the effectiveness of
any Registration Statement as soon as reasonably practicable; 

  

	 	iv.	 upon the occurrence of any event contemplated above, except for such times as the Company is permitted
hereunder to suspend, and has suspended, the use of a prospectus forming part of a Registration Statement, the Company shall use its commercially reasonable efforts to as soon as reasonably practicable prepare a post-effective amendment to such
Registration Statement or a supplement to the related prospectus, or file any other required document so that, as thereafter delivered to purchasers of the Shares included therein, such prospectus will not include any untrue statement of a material
fact or omit to state any material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; 

 

	 	v.	 use its commercially reasonable efforts to cause all Shares to be listed on each securities exchange or market,
if any, on which the Common Stock has been listed; 

  

	 	vi.	 cooperate with Subscriber to facilitate the timely preparation and delivery of certificates or book-entry
positions, upon the effectiveness of Registration Statement, representing Shares to be sold and not bearing any restrictive legends, including without limitation, the delivery, at the Company’s expense, of a legal opinion of the Company’s
counsel to the transfer agent (if required); and enable such Shares to be in such denominations and registered in such names as the Subscriber may reasonably request at least two (2) Business Days prior to the closing of any sale of Shares by
Subscriber pursuant to the Registration Statement or any applicable federal securities law exemption; and 

	 	vii.	 use its commercially reasonable efforts (A) to take all other steps necessary to effect the registration
of the Shares contemplated hereby and (B) for so long as the Subscriber holds Shares, to file all reports and other materials required to be filed by the Exchange Act so long as the Company remains subject to such requirements and the filing of
such reports and other documents is required for the applicable provisions of Rule 144 to enable the Subscriber to sell the Shares under Rule 144. 

c. The Company may delay filing or suspend the use of any such registration statement if the Company determines, upon advice of legal counsel,
that in order for the registration statement to not contain a material misstatement or omission, an amendment thereto or a supplement to the related prospectus would be needed, or if the Chief Executive Officer of the Company reasonable believes,
upon advice of legal counsel, such filing or use could materially affect a bona fide business or financing transaction of the Company or would require premature disclosure of information that could materially adversely affect the Company (each such
circumstance, a “Suspension Event”); provided, however, that the Company may not delay filing or suspend the use of any registration statement on more than three occasions or for more than ninety (90) consecutive
calendar days, or more than one hundred twenty (120) total calendar days, in each case during any twelve-month period. Upon receipt of any written notice from the Company of the happening of any Suspension Event during the period that the
Registration Statement is effective or if as a result of a Suspension Event the Registration Statement or related prospectus contains any untrue statement of a material fact or omits to state any material fact required to be stated therein or
necessary to make the statements therein, in light of the circumstances under which they were made (in the case of the prospectus) not misleading, the Subscriber agrees that it will (i) immediately discontinue offers and sales of the Shares
under the Registration Statement until the Subscriber receives (A) (x) copies of a supplemental or amended prospectus that corrects the misstatement(s) or omission(s) referred to above and (y) notice that any post-effective amendment has
become effective or (B) notice from the Company that it may resume such offers and sales, and (ii) maintain the confidentiality of any information included in such written notice delivered by the Company unless otherwise required by
applicable law. If so directed by the Company, the Subscriber will deliver to the Company or, in the Subscriber’s sole discretion destroy, all copies of the prospectus covering the Shares in the Subscriber’s possession; provided,
however, that this obligation to deliver or destroy all copies of the prospectus covering the Shares shall not apply to (i) the extent the Subscriber is required to retain a copy of such prospectus (A) in order to comply with
applicable legal, regulatory, self-regulatory or professional requirements or (B) in accordance with a bona fide pre-existing document retention policy or (ii) copies stored electronically on
archival servers as a result of automatic data back-up. 
 d. The Company shall indemnify, defend
and hold harmless the Subscriber (to the extent a seller under the Registration Statement), its officers, directors, partners, members, managers, stockholders, advisers and agents, and each person who controls the Subscriber (within the meaning of
Section 15 of the Securities Act or Section 20 of the Exchange Act), to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable and
documented out-of-pocket attorneys’ fees) and expenses (collectively, “Losses”), resulting from any untrue or alleged untrue statement of a
material fact contained in the Registration Statement, any prospectus included in the Registration Statement or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or any omission or alleged omission to
state a material fact required to be stated therein or necessary to make the statements therein (in the case of any prospectus or form of prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading,
except to the extent, and only to the extent, that such untrue statements, alleged untrue statements, omissions or alleged omissions are based upon information or furnished in writing to the Company by the Subscriber expressly for use therein.
Notwithstanding the forgoing, the Company’s indemnification obligations shall not apply to amounts paid in settlement of any Losses or action if such settlement is effected without the prior written consent of the Company (which consent shall
not be unreasonably withheld or delayed). 
 e. The Subscriber shall, separately and not jointly with any Other Subscriber, indemnify and
hold harmless the Company, its directors, officers, agents and employees, and each person who controls the Company (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers,
agents or employees of such controlling persons, to the fullest extent permitted by applicable law, from and against all Losses, resulting from any untrue or alleged untrue statement of a material fact contained in any Registration Statement, any
prospectus included in the Registration Statement, or any form of prospectus, or in any amendment or supplement thereto or in any preliminary prospectus, or any omission or alleged omission of a material fact required to be stated therein or
necessary to make the statements therein (in the case of any prospectus, or any form of prospectus or supplement thereto, in the light of the circumstances under which they were made) not misleading to the extent, and only to the extent, that such
untrue statements, alleged untrue statements, omissions or alleged 

 
omissions are based upon information furnished in writing to the Company by the Subscriber expressly for use therein. Notwithstanding the forgoing, the Subscriber’s indemnification
obligations shall not apply to amounts paid in settlement of any Losses or action if such settlement is effected without the prior written consent of the Subscriber (which consent shall not be unreasonably withheld or delayed). In no event shall the
liability of the Subscriber be greater in amount than the dollar amount of the net proceeds received by the Subscriber upon the sale of the Shares giving rise to such indemnification obligation. 

f. If the indemnification provided under this Section 6 from the indemnifying party is unavailable or insufficient to hold harmless an
indemnified party in respect of any losses, claims, damages, liabilities and expenses referred to herein, then the indemnifying party, in lieu of indemnifying the indemnified party, shall contribute to the amount paid or payable by the indemnified
party as a result of such losses, claims, damages, liabilities and expenses in such proportion as is appropriate to reflect the relative fault of the indemnifying party and the indemnified party, as well as any other relevant equitable
considerations. The relative fault of the indemnifying party and indemnified party shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact or
omission or alleged omission to state a material fact, was made by, or relates to information supplied by, such indemnifying party or indemnified party, and the indemnifying party’s and indemnified party’s relative intent, knowledge,
access to information and opportunity to correct or prevent such action. The amount paid or payable by a party as a result of the losses or other liabilities referred to above shall be subject to the limitations set forth in this Section 6 and
deemed to include any legal or other fees, charges or expenses reasonably incurred by such party in connection with any investigation or proceeding. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the
Securities Act) shall be entitled to contribution pursuant to this Section 6(f) from any person who was not guilty of such fraudulent misrepresentation. Each indemnifying party’s obligation to make a contribution pursuant to this
Section 6(f) shall be individual, not joint and several, and in no event shall the liability of the Subscriber hereunder exceed the net proceeds received by the Subscriber upon the sale of the Shares giving rise to such indemnification
obligation. 
 7. Termination. This Subscription Agreement shall terminate and be void and of no further force and
effect, and all rights and obligations of the parties hereunder shall terminate without any further liability on the part of any party in respect thereof, upon the earliest to occur of (a) upon the mutual written agreement of each of the
parties hereto to terminate this Subscription Agreement and (b) September 11, 2022, if the Closing has not occurred by such date; provided that (i) nothing herein will relieve any party from liability for any willful breach
hereof prior to the time of termination, and each party will be entitled to any remedies at law or in equity to recover losses, liabilities or damages arising from such breach, and (ii) the provisions of Sections 8 through 9 of
this Subscription Agreement will survive any termination of this Subscription Agreement and continue indefinitely. 
 8.
Miscellaneous. 
 a. Neither this Subscription Agreement nor any rights that may accrue to the Subscriber hereunder (other
than the Shares acquired hereunder, if any, subject to applicable securities laws) may be transferred or assigned by the Subscriber without the prior written consent of the Company, provided that the Subscriber may transfer or assign all or a
portion of its rights under this Subscription Agreement to an affiliate or to any fund or account managed by the same investment manager as the Subscriber, provided further that the Subscriber shall provide notice to the Company upon such
transfer. Any purported transfer or assignment in violation of this Section 8(a) shall be null and void ab initio. 
 b. The Company
may request from the Subscriber such additional information as the Company may deem necessary to evaluate the eligibility of the Subscriber to acquire the Shares, and the Subscriber shall provide such information to the Company upon such request to
the extent readily available and to the extent consistent with the Subscriber’s internal policies and procedures, and provided that the Company agrees to keep any such information provided by the Subscriber confidential unless otherwise
required by law, subpoena or regulatory request or requirement. 
 c. The Subscriber acknowledges that the Company, the Placement Agents and
others will rely on the acknowledgments, understandings, agreements, representations and warranties of the Subscriber contained in this Subscription Agreement, provided, however that the Closing may only be enforced against the
Subscriber by the 

 
Company. Prior to the Closing, the Subscriber agrees to promptly notify the Company if any of the acknowledgments, understandings, agreements, representations and warranties set forth herein are
no longer accurate in any material respect. The Subscriber agrees that the purchase by the Subscriber of Shares from the Company will constitute a reaffirmation of the acknowledgments, understandings, agreements, representations and warranties
herein (as modified by any such notice) by the Subscriber as of the time of such purchase. The Subscriber acknowledges and agrees that the Placement Agents are third-party beneficiaries of the representations, warranties and covenants of the
Subscriber contained in Section 5 and Section 9 of this Subscription Agreement. Except as expressly set forth herein, this Subscription Agreement shall not confer any rights or remedies upon any person other than the parties hereto, and
their respective successor and assigns. 
 d. The Company is entitled to rely upon this Subscription Agreement and is irrevocably authorized
to produce this Subscription Agreement or a copy hereof to any interested party in any administrative or legal proceeding or official inquiry with respect to the matters covered hereby. The Subscriber acknowledges that the Company may file a copy of
this Subscription Agreement with the SEC as an exhibit to a periodic report or a registration statement of the Company. Prior to the Closing, the Subscriber shall not issue any press release or make any other similar public statement with respect to
the transactions contemplated hereby without the prior written consent of the Company (such consent not to be unreasonably withheld or delayed). 

e. All the agreements, representations and warranties made by each party hereto in this Subscription Agreement shall survive the Closing. 

f. This Subscription Agreement may not be amended, modified, waived or terminated except by an instrument in writing, signed by the party
against whom enforcement of such amendment, modification, waiver or termination is sought. 
 g. This Subscription Agreement constitutes the
entire agreement, and supersedes all other prior agreements, understandings, representations and warranties, both written and oral, among the parties, with respect to the subject matter hereof. 

h. Except as otherwise provided herein, this Subscription Agreement shall be binding upon, and inure to the benefit of the parties hereto and
their heirs, executors, administrators, successors, legal representatives, and permitted assigns, and the agreements, representations, warranties, covenants and acknowledgments contained herein shall be deemed to be made by, and be binding upon,
such heirs, executors, administrators, successors, legal representatives and permitted assigns. 
 i. If any provision of this Subscription
Agreement shall be invalid, illegal or unenforceable, the validity, legality or enforceability of the remaining provisions of this Subscription Agreement shall not in any way be affected or impaired thereby and shall continue in full force and
effect. 
 j. This Subscription Agreement may be executed and delivered in one or more counterparts and by different parties in separate
counterparts, with the same effect as if all parties hereto had signed the same document. Counterparts may be delivered via facsimile, electronic mail (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform
Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., .pdf or www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and
be valid and effective for all purposes. All counterparts so executed and delivered shall be construed together and shall constitute one and the same agreement. 

k. The parties hereto agree that irreparable damage would occur in the event that any of the provisions of this Subscription Agreement were
not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties shall be entitled to an injunction or injunctions to prevent breaches of this Subscription Agreement and to enforce
specifically the terms and provisions of this Subscription Agreement, this being in addition to any other remedy to which such party is entitled at law, in equity, in contract, in tort or otherwise. 

l. THIS SUBSCRIPTION AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO
THE PRINCIPLES OF CONFLICTS OF LAWS THAT WOULD OTHERWISE REQUIRE THE APPLICATION OF THE LAW OF ANY OTHER STATE.  

 m. EACH PARTY HERETO HEREBY WAIVES ITS RESPECTIVE RIGHTS TO A TRIAL BY JURY OF ANY CLAIM
OR CAUSE OF ACTION BASED UPON OR ARISING OUT OR RELATED TO THIS SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY IN ANY ACTION, PROCEEDING OR OTHER LITIGATION OF ANY TYPE BROUGHT BY ANY PARTY HERETO AGAINST
ANY OTHER PARTY HERETO OR ANY AFFILIATE OF ANY OTHER SUCH PARTY, WHETHER WITH RESPECT TO CONTRACT CLAIMS, TORT CLAIMS OR OTHERWISE. THE PARTIES HERETO AGREE THAT ANY SUCH CLAIM OR CAUSE OF ACTION SHALL BE TRIED BY A COURT TRIAL WITHOUT A JURY.
WITHOUT LIMITING THE FOREGOING, THE PARTIES HERETO FURTHER AGREE THAT THEIR RESPECTIVE RIGHT TO A TRIAL BY JURY IS WAIVED BY OPERATION OF THIS SECTION AS TO ANY ACTION, COUNTERCLAIM OR OTHER PROCEEDING WHICH SEEKS, IN WHOLE OR IN PART, TO CHALLENGE
THE VALIDITY OR ENFORCEABILITY OF THIS SUBSCRIPTION AGREEMENT OR ANY PROVISION HEREOF. THIS WAIVER SHALL APPLY TO ANY SUBSEQUENT AMENDMENTS, RENEWALS, SUPPLEMENTS OR MODIFICATIONS TO THIS SUBSCRIPTION AGREEMENT. 

n. THE PARTIES HERETO AGREE THAT ALL DISPUTES, LEGAL ACTIONS, SUITS AND PROCEEDINGS ARISING OUT OF OR RELATING TO THIS SUBSCRIPTION AGREEMENT
MUST BE BROUGHT EXCLUSIVELY IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK OR ANY NEW YORK STATE COURT SITTING IN NEW YORK CITY, NEW YORK, AND ANY APPELLATE COURT THEREFROM (COLLECTIVELY THE “DESIGNATED
COURTS”). EACH PARTY HERETO HEREBY CONSENTS AND SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE DESIGNATED COURTS. NO LEGAL ACTION, SUIT OR PROCEEDING WITH RESPECT TO THIS SUBSCRIPTION AGREEMENT MAY BE BROUGHT IN ANY OTHER FORUM. EACH PARTY
HERETO HEREBY IRREVOCABLY WAIVES ALL CLAIMS OF IMMUNITY FROM JURISDICTION AND ANY OBJECTION WHICH SUCH PARTY MAY NOW OR HEREAFTER HAVE TO THE LAYING OF VENUE OF ANY SUIT, ACTION OR PROCEEDING IN ANY DESIGNATED COURT, INCLUDING ANY RIGHT TO OBJECT ON
THE BASIS THAT ANY DISPUTE, ACTION, SUIT OR PROCEEDING BROUGHT IN THE DESIGNATED COURTS HAS BEEN BROUGHT IN AN IMPROPER OR INCONVENIENT FORUM OR VENUE. EACH OF THE PARTIES HERETO ALSO AGREES THAT DELIVERY OF ANY PROCESS, SUMMONS, NOTICE OR DOCUMENT
TO A PARTY HEREOF IN COMPLIANCE WITH SECTION 9(O) SHALL BE EFFECTIVE SERVICE OF PROCESS FOR ANY ACTION, SUIT OR PROCEEDING IN A DESIGNATED COURT WITH RESPECT TO ANY MATTERS TO WHICH THE PARTIES HERETO HAVE SUBMITTED TO JURISDICTION AS SET FORTH
ABOVE. 
 o. All notices, requests, demands, claims and other communications hereunder shall be in writing. Any notice, request, demand,
claim or other communication hereunder shall be deemed duly given (i) when delivered personally to the recipient, (ii) when sent by electronic mail, on the date of transmission to such recipient, (iii) one (1) business day after being
sent to the recipient by reputable overnight courier service (charges prepaid), or (iv) three (3) business days after being mailed to the recipient by certified or registered mail, return receipt requested and postage prepaid, and, in each
case, addressed to the intended recipient at its address specified on the signature page hereof or to such electronic mail address or address as subsequently modified by written notice given in accordance with this Section 8(o): 

 

			
	 If to the Company, to:

GreenLight BioSciences Holdings, PBC
 200 Boston
Avenue
 Medford, MA 02155
 Attention:

E-mail:
 Telephone
No.:
	  	 with copies (which shall not constitute notice) to:

Goodwin Procter LLP
 620 Eighth Avenue

New York, NY 10018
 Attention: Jeffrey A. Letalien

E-mail: jletalien@goodwinlaw.com

Telephone No.: (212) 459-7203

 Notice to the Subscriber shall be given to the address underneath the Subscriber’s name on the signature page hereto.

 p. The headings set forth in this Subscription Agreement are for convenience of reference
only and shall not be used in interpreting this Subscription Agreement. In this Subscription Agreement, unless the context otherwise requires: (i) whenever required by the context, any pronoun used in this Subscription Agreement shall include
the corresponding masculine, feminine or neuter forms, and the singular form of nouns, pronouns and verbs shall include the plural and vice versa; (ii) “including” (and with correlative meaning “include”) means including without
limiting the generality of any description preceding or succeeding such term and shall be deemed in each case to be followed by the words “without limitation”; and (iii) the words “herein”, “hereto” and
“hereby” and other words of similar import in this Subscription Agreement shall be deemed in each case to refer to this Subscription Agreement as a whole and not to any particular portion of this Subscription Agreement. As used in this
Subscription Agreement, the term: (x) “business day” shall mean any day other than a Saturday, Sunday or a legal holiday on which commercial banking institutions in New York, New York are authorized to close for business (excluding as a
result of “stay at home”, “shelter-in-place”, “non-essential employee” or any other similar orders
or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems, including for wire transfers, of commercially banking institutions in New York, New York
are generally open for use by customers on such day); (y) “person” shall refer to any individual, corporation, partnership, trust, limited liability company or other entity or association, including any governmental or regulatory body,
whether acting in an individual, fiduciary or any other capacity; and (z) “affiliate” shall mean, with respect to any specified person, any other person or group of persons acting together that, directly or indirectly, through one or more
intermediaries controls, is controlled by or is under common control with such specified person (where the term “control” (and any correlative terms) means the possession, direct or indirect, of the power to direct or cause the direction
of the management and policies of such person, whether through the ownership of voting securities, by contract or otherwise). 
 q. The
obligations of the Subscriber under this Subscription Agreement are several and not joint with the obligations of any Other Subscriber or any other investor under the Other Subscription Agreements, and the Subscriber shall not be responsible in any
way for the performance of the obligations of any Other Subscriber under this Subscription Agreement or any other investor under the Other Subscription Agreements. Nothing contained herein or in any Other Subscription Agreement, and no action taken
by the Subscriber or investor pursuant hereto or thereto, shall be deemed to constitute the Subscriber and other investors as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Subscriber and
other investors are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by this Subscription Agreement and the Other Subscription Agreements. The Subscriber acknowledges that no Other
Subscriber has acted as agent for the Subscriber in connection with making its investment hereunder and no Other Subscriber will be acting as agent of the Subscriber in connection with monitoring its investment in the Shares or enforcing its rights
under this Subscription Agreement. The Subscriber shall be entitled to independently protect and enforce its rights, including without limitation the rights arising out of this Subscription Agreement, and it shall not be necessary for any Other
Subscriber or investor to be joined as an additional party in any proceeding for such purpose. 
 r. The Subscriber understands and agrees
that the Subscriber is purchasing the Shares directly from the Company. The Subscriber further acknowledges that there have not been, and the Subscriber hereby agrees that it is not relying on, any representations, warranties, covenants or
agreements made to the Subscriber by the Company, any of the Company’s representatives or any other person or entity, expressly or by implication, other than those representations, warranties, covenants and agreements of the Company set forth
in this Subscription Agreement. The Subscriber acknowledges that certain information provided by the Company was based on projections, and such projections were prepared based on assumptions and estimates that are inherently uncertain and are
subject to a wide variety of significant business, economic and competitive risks and uncertainties that could cause actual results to differ materially from those contained in the projections. 

s. At Closing, the parties hereto shall execute and deliver such additional documents and take such additional actions as the parties may
reasonably deem practical and necessary in order to consummate the Offering as contemplated by this Subscription Agreement. 
 t.
Notwithstanding anything herein to the contrary, the Company shall pay all transfer agent fees (including, without limitation, any fees required for same-day processing of any instruction letter delivered by
the Company delivered by Subscriber), stamp taxes and other taxes and duties levied in connection with the delivery of any securities to Subscriber other than income and capital gains taxes of the Subscriber that may be incurred in connection with
the transaction contemplated hereby. 

 9. Non-Reliance and
Exculpation. The Subscriber acknowledges that it is not relying upon, and has not relied upon, any statement, representation or warranty made by any person other than the statements, representations and warranties contained in this
Subscription Agreement in making its investment or decision to invest in the Company. The Subscriber agrees that neither (i) any Other Subscriber pursuant to the Other Subscription Agreements (including the controlling persons, members,
officers, directors, partners, agents, or employees of any such Other Subscriber) nor (ii) each Placement Agent, its affiliates or any of its or its affiliates’ respective control persons, officers, directors or employees, shall be liable
to the Subscriber pursuant to this Subscription Agreement for any action heretofore or hereafter taken or omitted to be taken by any of them in connection with the purchase of the Shares. 

10. Disclosure. The Company shall, by 9:00 a.m., New York City time, on the first (1st) business day immediately
following the date of this Subscription Agreement, issue one or more press releases or file with the SEC a Current Report on Form 8-K (collectively, the “Press Release”) disclosing all
material terms of the transactions contemplated hereby and by the Other Subscription Agreements and any other material, nonpublic information that the Company has provided to the Subscriber at any time prior to the filing of the Press Release. Upon
the issuance of the Press Release, to the Company’s knowledge, the Subscriber shall not be in possession of any material, non-public information received from the Company or any of its officers, directors
or employees or agents (including the Placement Agents) and the Subscriber shall no longer be subject to any confidentiality or similar obligations under any current agreement, whether written or oral with the Company, the Placement Agents or any of
their respective affiliates. Notwithstanding anything in this Subscription Agreement to the contrary, the Company shall not publicly disclose the name of the Subscriber, its investment adviser, if applicable, or any of its affiliates, or include the
name of the Subscriber, its investment adviser, if applicable, or any of its affiliates in any press release or in any filing with the SEC or any regulatory agency or trading market, without the prior written consent of the Subscriber, except
(i) as required by the federal securities law and (ii) to the extent such disclosure is required by law, at the request of the Staff of the SEC or regulatory agency or under the regulations of NASDAQ, in which case the Company shall
provide the Subscriber with prior written notice of such disclosure permitted under the foregoing clauses (i) and (ii). 
 11.
Placement Agent Matters. Each party hereto agrees for the express benefit of the Placement Agents that: 
 a. The Placement
Agents (i) have no duties or obligations as placement agents other than those specifically set forth herein or in the letter agreement by and between the Company and Credit Suisse, dated as of July 18, 2022, and the letter agreement by and
between the Company and Baird, dated as of July 20, 2022 (the “Letter Agreements”); (ii) shall not be liable for any improper payment made in accordance with the information provided by the Company; (iii) make no
representation or warranty, or have no responsibilities as to the validity, accuracy, value or genuineness of any information, certificates or documentation delivered by or on behalf of the Company pursuant to this Subscription Agreement or in
connection with any of the transactions contemplated herein; or (iv) shall not be liable (x) for any action taken, suffered or omitted by any of them in good faith and reasonably believed to be authorized or within the discretion or rights
or powers conferred upon it by this Subscription Agreement or (y) for anything which any of them may do or refrain from doing in connection with this Subscription Agreement, except for such party’s own gross negligence, willful misconduct
or bad faith. 
 b. The Placement Agents shall be entitled to (i) rely on, and shall be protected in acting upon, any certificate,
instrument, opinion, notice, letter or any other document or security delivered to any of them by or on behalf of the Company, and (ii) be indemnified by the Company for acting as placement agents hereunder pursuant the indemnification
provisions set forth in the Letter Agreements. 
 {SIGNATURE PAGES FOLLOW} 

 IN WITNESS WHEREOF, the parties hereto have caused this Subscription Agreement to be duly
executed by their respective authorized signatories as of the date first indicated above. 
  

			
	 GreenLight Biosciences Holdings, PBC

		
	 By:
	 	 
	 	 	Name:
	 	 	Title:

 [Signature Page to Subscription Agreement] 

 IN WITNESS WHEREOF, the undersigned has caused this Subscription Agreement to be duly
executed by its authorized signatory as of the date set forth below. 
  

	
	SUBSCRIBER
	
Name(s) of Subscriber:             
                                         
      

	
	 Signature of Authorized Signatory of Subscriber:

	
	 
	 Name of Authorized Signatory:

	 Title of Authorized Signatory:

	 Address for Notice to Subscriber:

	 Attention:

	 Email:

	 Facsimile No.:

	 Telephone No.:

	
	Address for Delivery of Shares to Subscriber (if not same as address for notice):

  

					
	 Subscription Amount:
	  	$	         	 
	 Number of Shares:
	  			
	 EIN:
	  			

 [Subscriber Signature Page to the Subscription Agreement] 

 Exhibit A 

Accredited Investor Questionnaire 

Capitalized terms used and not defined in this Exhibit A shall have the meanings given in the Subscription Agreement to which this Exhibit A is
attached. The undersigned represents and warrants that the undersigned is an “accredited investor” (an “Accredited Investor”) as such term is defined in Rule 501(a) of Regulation D under the U.S. Securities Act of 1933, as
amended (the “Securities Act”), for one or more of the reasons specified below (please check all boxes that apply): 
  

			
		
	_______	  	 (i)  A natural person whose net worth, either individually or jointly with such
person’s spouse or spousal equivalent, at the time of the Subscriber’s purchase, exceeds $1,000,000;

		
		  	 The term “net worth” means the excess of total assets over total liabilities (including personal and real
property, but excluding the estimated fair market value of the Subscriber’s primary home). For the purposes of calculating joint net worth with the person’s spouse or spousal equivalent, joint net worth can be the aggregate net
worth of the Subscriber and spouse or spousal equivalent; assets need not be held jointly to be included in the calculation. There is no requirement that securities be purchased jointly.

		
	_______	  	 (ii)   A natural person who had an individual income in excess of $200,000, or
joint income with the Subscriber’s spouse or spousal equivalent in excess of $300,000, in each of the two most recent years and reasonably expects to reach the same income level in the current year;

		
		  	 In determining individual “income,” the Subscriber should add to the Subscriber’s individual taxable
adjusted gross income (exclusive of any spousal or spousal equivalent income) any amounts attributable to tax exempt income received, losses claimed as a limited partner in any limited partnership, deductions claimed for depletion, contributions to
an IRA or Keogh retirement plan, alimony payments, and any amount by which income from long-term capital gains has been reduced in arriving at adjusted gross income.

		
	_______	  	 (iii)   A director or executive officer of the Company;

		
	_______	  	 (iv)  A natural person holding in good standing with one or more professional
certifications or designations or other credentials from an accredited educational institution that the U.S. Securities Exchange Commission (“SEC”) has designated as qualifying an individual for accredited investor
status;

		
		  	 The SEC has designated the General Securities Representative license (Series 7), the Private Securities Offering
Representative license (Series 82) and the Licensed Investment Adviser Representative (Series 65) as the initial certifications that qualify for accredited investor status.

		
	_______	  	 (v)    A natural person who is a “knowledgeable employee” as
defined in Rule 3c-5(a)(4) under the Investment Company Act of 1940 (the “Investment Company Act”), of the issuer of the securities being offered or sold where the issuer would be an
investment company, as defined in section 3 of the Investment Company Act, but for the exclusion provided by either section 3(c)(1) or section 3(c)(7) of the Investment Company Act;

		
	_______	  	 (vi)  A bank as defined in Section 3(a)(2) of the Securities Act, or any savings
and loan association or other institution as defined in Section 3(a)(5)(A) of the Securities Act, whether acting in its individual or fiduciary capacity;

		
	_______	  	 (vii)  A broker or dealer registered pursuant to Section 15 of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”);

		
	_______	  	 (viii)   An investment adviser registered pursuant to section 203 of the
Investment Advisers Act of 1940 (the “Investment Advisers Act”) or registered pursuant to the laws of a state, or an investment adviser relying on the exemption from registering with the SEC under the section 203(l) or (m) of
the Investment Advisers Act;

		
	_______	  	 (ix)  An insurance company as defined in section 2(13) of the Exchange
Act;

		
	_______	  	 (x)    An investment company registered under the Investment Company Act
or a business development company as defined in Section 2(a)(48) of that Act;

		
	_______	  	 (xi)  A Small Business Investment Company licensed by the U.S. Small Business
Administration under Section 301(c) or (d) of the Small Business Investment Act of 1958;

		
	_______	  	 (xii)  A Rural Business Investment Company as defined in section 384A of the
Consolidated Farm and Rural Development Act;

		
	_______	  	 (xiii)   A plan established and maintained by a state, its political
subdivisions, or any agency or instrumentality of a state, or its political subdivisions for the benefit of its employees, if such plan has total assets in excess of $5,000,000;

			
	 _______
	 	 (xiv) An employee benefit plan within the meaning of the Employee Retirement Income Security
Act of 1974, if the investment decision is made by a plan fiduciary, as defined in Section 3(21) of such act, which is either a bank, savings and loan association, insurance company, or registered investment adviser, or if the employee benefit
plan has total assets in excess of $5,000,000 or, if a self-directed plan, with investment decisions made solely by persons that are accredited investors;

		
	 _______
	 	 (xv)   A private business development company as defined in
Section 202(a)(22) of the Investment Advisers Act of 1940;

		
	 _______
	 	 (xvi) An organization described in Section 501(c)(3) of the Internal Revenue Code, or a
corporation, business trust, partnership, or limited liability company, or any other entity not formed for the specific purpose of acquiring the Shares, with total assets in excess of $5,000,000;

		
	 _______
	 	 (xvii)  A trust, with total assets in excess of $5,000,000, not formed for the
specific purpose of acquiring the Shares, whose purchase is directed by a sophisticated person who has such knowledge and experience in financial and business matters that such person is capable of evaluating the merits and risks of investing in the
Company;

		
	 _______
	 	 (xviii)  A “family office” as defined in Rule
202(a)(11)(G)-1 under the Investment Advisers Act with assets under management in excess of $5,000,000 that is not formed for the specific purpose of acquiring the securities offered and whose prospective
investment is directed by a person who has such knowledge and experience in financial and business matters that such family office is capable of evaluating the merits and risks of the prospective investment;

		
	 _______
	 	 (xix) A “family client” as defined in Rule
202(a)(11)(G)-1 under the Investment Advisers Act, of a family office meeting the requirements set forth in (xviii) and whose prospective investment in the issuer is directed by a person from a family
office that is capable of evaluating the merits and risks of the prospective investment;

		
	 _______
	 	 (xx)   An entity, of a type not listed above, not formed for the specific
purpose of acquiring the securities offered, owning investments in excess of $5,000,000; and/or

		
	 _______
	 	 (xxi) An entity in which all of the equity owners qualify as an accredited investor
under any of the above subparagraphs.

		
	 _______
	 	 (xxii)  The Subscriber does not qualify under any of the investor categories set forth
in (i) through (xxi) above.

  

	2.1	 Type of the Subscriber. Indicate the form of entity of the Subscriber: 

 

							
	☐	  	Individual	  	☐	  	Limited Partnership
	☐	  	Corporation	  	☐	  	General Partnership
	☐	  	Revocable Trust	  	 	  	 
	☐	  	Other Type of Trust (indicate type):_______________________
	☐	  	Other (indicate form of organization):_______________________

  

	2.2.1	 If the Subscriber is not an individual, indicate the approximate date the Subscriber entity was formed:
___________________. 

  

	2.2.2	 If the Subscriber is not an individual, initial the line below which correctly describes the
application of the following statement to the Subscriber’s situation: the Subscriber (x) was not organized or reorganized for the specific purpose of acquiring the Shares and (y) has made investments prior to the date hereof, and each
beneficial owner thereof has and will share in the investment in proportion to his or her ownership interest in the Subscriber. 

__________ True 
 __________ False

 If the “False” line is initialed, each person participating in the entity will be required to fill out a Subscription
Agreement. 
  

			
	 Subscriber:

Subscriber
Name:     _________________________________________

	         By:
	 	 
	         Signatory Name:

	         Signatory Title:Exhibit 4.6

 

MOVANO INC.

2021 INDUCEMENT
AWARD PLAN

 

Movano Inc., a Delaware
corporation sets forth herein the terms of its 2021 Inducement Award Plan.

 

		1.	PURPOSE

 

The purpose of the Plan is to provide, among other
equity awards, non-qualified stock options to individuals not previously employees of the Company (or following such individuals’
bona fide period of non-employment with the Company), as an inducement material to the individuals’ entry into employment with the
Company within the meaning of Rule 5635(c)(4) of the NASDAQ Listing Rules. It is anticipated that providing such persons with a direct
stake in the Company’s welfare will assure a closer identification of their interests with those of the Company and its stockholders,
thereby stimulating their efforts on the Company’s behalf and strengthening their desire to remain with the Company.

 

		2.	DEFINITIONS

 

For purposes of interpreting the Plan and related
documents (including Award Agreements), the following definitions shall apply:

 

2.1. “2019
Omnibus Plan” means the Company’s 2019 Amended and Restated Omnibus Incentive Plan, as amended
from time to time.

 

2.2. “Alternative
Award” means an Award made pursuant to Section 8.2.

 

2.3. “Award”
means an Inducement Non-Qualified Stock Option Award or an Alternative Award.

 

2.4. “Award
Agreement” means a written agreement between the Company and a Grantee, or notice from the Company
to a Grantee that evidences and sets out the terms and conditions of an Award.

 

2.5. “Board”
means the Board of Directors of the Company.

 

2.6. “Committee”
means the Compensation Committee of the Board.

 

2.7. “Common
Stock” means the common stock, par value $0.0001, of the Company.

 

2.8. “Company”
means Movano Inc., a Delaware corporation, or any successor corporation.

 

2.9. “Effective
Date” means September 15, 2021.

 

2.10. “Eligible
Individual” means any individual who was not previously an employee of the Company or any of its
Subsidiaries (or who has had a bona fide period of non-employment with the Company and its Subsidiaries) who is hired by the Company or
one of its Subsidiaries.

 

     

     

    

 

2.11. “Fair
Market Value” of a Share as of a particular date means (i) if the Common Stock is listed on a
national securities exchange, the closing or last price of the Common Stock on the composite tape or other comparable reporting system
for the applicable date, or if the applicable date is not a trading day, the trading day immediately preceding the applicable date, or
(ii) if the Common Stock is not then listed on a national securities exchange, the closing or last price of the Common Stock quoted by
an established quotation service for over-the-counter securities, or (iii) if the Common Stock is not then listed on a national securities
exchange or quoted by an established quotation service for over-the-counter securities, or the value of the Common Stock is not otherwise
determinable, such value as determined by the Committee. 

 

2.12. “Grant
Date” means the latest to occur of (i) the date as of which the Committee approves an Award, (ii)
the date on which the recipient of an Award first becomes eligible to receive an Award under Section 8 or (iii) such other date as may
be specified by the Committee in the Award Agreement.

 

2.13. “Grantee”
means a person who receives or holds an Award under the Plan.

 

2.14. “Inducement
Non-Qualified Stock Option Award” is defined in Section 8.1.

 

2.15. “Issued
Shares” means, collectively, all outstanding Shares issued pursuant to Awards (including Shares
issued in connection with the exercise of an Inducement Non-Qualified Stock Option Award).

 

2.16. “Plan”
means this Movano Inc. 2021 Inducement Award Plan.

 

2.17. “Separation
from Service” means the termination of a Grantee’s service as an employee of the Company,
whether initiated by the Grantee or the Company or an Affiliate; provided that if any Award governed by Section 409A is to be distributed
on a Separation from Service, then the definition of Separation from Service for such purposes shall comply with the definition provided
in Section 409A. Unless otherwise provided in the applicable Award Agreement, a Grantee’s change in position or duties shall not
result in interrupted or terminated service, so long as such Grantee continues to be an employee of the Company.

 

2.18. “Share”
means a share of Common Stock.

 

2.19. “Termination
Date” means September 15, 2024.

 

Any capitalized terms used but not defined herein
are defined in the 2019 Omnibus Plan.

 

    2

     

    

 

		3.	ADMINISTRATION OF THE PLAN

 

3.1. General

 

The Board shall have such powers and authorities
related to the administration of the Plan as are consistent with the Company’s certificate or articles of incorporation, bylaws
and applicable law, and as further described herein. To the extent permitted by applicable law, the Board shall have the power and authority
to delegate its powers and responsibilities hereunder to the Committee, which shall have full authority to act in accordance with its
charter, and with respect to the authority of the Board to act hereunder. All references to the Board shall be deemed to include a reference
to the Committee, to the extent such power or responsibilities of the board have been delegated. The Committee shall administer the Plan;
provided that the Board shall retain the right to exercise the authority of the Committee to the extent consistent with applicable law
and the applicable requirements of any securities exchange on which Common Stock may then be listed. Except as specifically provided in
Section 13 or as otherwise may be required by applicable law, regulatory requirement or the certificate or articles of incorporation or
the bylaws of the Company, the Board shall have full power and authority to take all actions and to make all determinations required or
provided for under the Plan, any Award or any Award Agreement, and shall have full power and authority to take all such other actions
and make all such other determinations not inconsistent with the specific terms and conditions of the Plan that the Board deems to be
necessary or appropriate to the administration of the Plan. The actions, determinations, interpretation, construction and decisions by
the Board with respect to the Plan, any Award or any Award Agreement shall be in the Board’s sole discretion and shall be final,
binding and conclusive. Without limitation, the Board shall have full and final power and authority, subject to the other terms and conditions
of the Plan, to::

 

(i) designate Grantees;

 

(ii) determine the type or types of
Awards to be made to a Grantee;

 

(iii) determine the number of shares
of Stock to be subject to an Award;

 

(iv) establish the terms and conditions
of each Award (including, but not limited to, the Option Price of any Inducement Non-Qualified Stock Option Award, the nature and duration
of any restriction or condition (or provision for lapse thereof) relating to the vesting, exercise, transfer, or forfeiture of an Award
or the Shares subject thereto);

 

(v) prescribe the form of each Award
Agreement; and

 

(vi) amend, modify, or supplement the
terms of any outstanding Award including the authority, in order to effectuate the purposes of the Plan, to modify Awards to foreign nationals
or individuals who are employed outside the United States to recognize differences in local law, tax policy, or custom.

 

3.2. No
Liability

 

No member of the Board or of the Committee shall
be liable for any action or determination made in good faith with respect to the Plan, any Award or Award Agreement.

 

3.3. Book
Entry

 

Notwithstanding any other provision of this Plan
to the contrary, the Company may elect to satisfy any requirement under this Plan for the delivery of stock certificates through the use
of book-entry.

 

		4.	STOCK SUBJECT TO THE PLAN

 

4.1. Authorized
Number of Shares

 

Subject to adjustment under Section 10,
the aggregate number of Shares that may be initially issued pursuant to the Plan is 2,000,000 Shares.

 

    3

     

    

 

4.2. Share
Counting

 

4.2.1 General

 

Each Share granted in connection with an Award shall
be counted as one Share against the limit in Section 4.1, subject to the provisions of this Section 4.2.

 

4.2.2 Cash-Settled Awards

 

Any Award settled in cash shall not be counted as
issued Shares for any purpose under the Plan.

 

4.2.3 Expired or Terminated Awards

 

If any Award expires, or is terminated, surrendered
or forfeited, in whole or in part, the unissued Shares covered by such Award shall again be available for the grant of Awards.

 

4.2.4 Payment of Option Price or Tax Withholding
in Shares

 

If Shares issuable upon exercise, vesting or settlement
of an Award, or Shares owned by a Grantee (which are not subject to any pledge or other security interest) are surrendered or tendered
to the Company in payment of an Inducement Non-Qualified Stock Option Award or any taxes required to withheld in respect of an Award,
in each case, in accordance with the terms and conditions of the Plan and any applicable Award Agreement, such surrendered or tendered
Shares shall again be available for the grant of Awards.

 

		5.	EFFECTIVE DATE, DURATION AND AMENDMENTS

 

5.1. Term

 

The Plan shall be effective as of the Effective
Date. The Plan shall terminate automatically on the Termination Date and may be terminated on any earlier date as provided in Section 5.2.

 

5.2. Amendment
and Termination of the Plan

 

The Board may, at any time and from time to time,
amend, suspend, or terminate the Plan as to any Awards which have not been made. An amendment shall be contingent on approval of the Company’s
stockholders to the extent stated by the Board, required by applicable law or required by applicable stock exchange listing requirements.
No Awards shall be made after the Termination Date. The applicable terms of the Plan, and any terms and conditions applicable to Awards
granted prior to the Termination Date shall survive the termination of the Plan and continue to apply to such Awards. No amendment, suspension,
or termination of the Plan shall, without the consent of the Grantee, materially impair rights or obligations under any Award theretofore
awarded.

 

    4

     

    

 

		6.	ELIGIBILITY

 

Grantees under the Plan will be such Eligible Individuals
as are selected from time to time by the Board in its sole discretion, and such Grantees shall be eligible to receive an Award in accordance
with Section 8.

 

		7.	AWARD AGREEMENT

 

The grant of any Award may be contingent upon the
Grantee executing an appropriate Award Agreement, in such form or forms as the Board shall from time to time determine. Without limiting
the foregoing, an Award Agreement may be provided in the form of a notice that provides that acceptance of the Award constitutes acceptance
of all terms and conditions of the Plan and the notice. Award Agreements granted from time to time or at the same time need not contain
similar provisions but shall be consistent with the terms and conditions of the Plan.

 

		8.	awards

 

8.1. Inducement
Non-Qualified Stock Option Awards

 

The Board may, from time to time and in its sole
discretion, grant to Grantees an award of non-qualified stock options (an “Inducement Non-Qualified Stock Option Award”)
in such form as the Board may from time to time approve.

 

8.1.1 Option Price.

 

The Option Price of each Inducement Non-Qualified
Stock Option Award shall be fixed by the Board and stated in the related Award Agreement.

 

8.1.2 Vesting.

 

Subject to Section 8.1.3, each Inducement
Non-Qualified Stock Option Award shall become exercisable at such times and under such conditions (including performance requirements)
as stated in the Award Agreement.

 

8.1.3 Term

 

Each Inducement Non-Qualified Stock Option Award,
and all rights to purchase Shares thereunder shall cease, upon the expiration of 10 years from the Grant Date, or under such circumstances
and on such date prior thereto as is set forth in the Plan or as may be fixed by the Board and stated in the related Award Agreement.

 

8.1.4 Limitations on Exercise of Option

 

Notwithstanding any other provision of the
Plan, in no event may any Inducement Non-Qualified Stock Option Award be exercised, in whole or in part, after the occurrence of an event
that results in termination of the Inducement Non-Qualified Stock Option Award.

 

8.1.5 Method of Exercise

 

An Inducement Non-Qualified Stock Option Award
that is exercisable may be exercised by the Grantee’s delivery of a notice of exercise to the Company, setting forth the number
of Shares with respect to which the Inducement Non-Qualified Stock Option Award is to be exercised, accompanied by full payment for the
Shares. To be effective, notice of exercise must be made in accordance with procedures established by the Board from time to time.

 

    5

     

    

 

8.1.6 Rights of Holders of Inducement Non-Qualified
Stock Option Awards

 

Unless otherwise provided in the applicable
Award Agreement, an individual holding or exercising an Inducement Non-Qualified Stock Option Award shall have none of the rights of a
stockholder (for example, the right to receive cash or dividend payments or distributions attributable to the subject Shares or to direct
the voting of the subject Shares) until the Shares covered thereby are fully paid an issued to him. Except as provided in Section 10
or the related Award Agreement, no adjustment shall be made for dividends, distribution or other rights for which the record date is prior
to the date of such issuance.

 

8.2. Other
Awards

 

In addition to Inducement Non-Qualified Stock Option
Awards granted pursuant to Section 8.1, the Board is authorized to grant an alternative form of Award (other than Incentive Stock
Options), as long as such form of Award is provided for in the 2019 Omnibus Plan.

 

		9.	requirements of law

 

9.1. General

 

The Company shall not be required to sell or issue
any Shares under any Award if the sale or issuance of such Shares would constitute a violation by the Grantee, any other individual exercising
an Inducement Non-Qualified Stock Option Award, or the Company of any provision of any law or regulation of any governmental authority,
including any federal or state securities laws or regulations. If at any time the Board determines that the listing, registration or qualification
of any Shares subject to an Award upon any securities exchange or under any governmental regulatory body is necessary or desirable as
a condition of, or in connection with, the issuance or purchase of Shares hereunder, no Shares may be issued or sold to the Grantee or
any other individual exercising an Inducement Non-Qualified Stock Option Award pursuant to such Award unless such listing, registration,
qualification, consent or approval shall have been effected or obtained free of any conditions not acceptable to the Company, and any
delay caused thereby shall in no way affect the date of termination of the Award. Specifically, in connection with the Securities Act,
upon the exercise of any Inducement Non-Qualified Stock Option Award or the delivery of any Shares underlying an Award, unless a registration
statement under such Act is in effect with respect to the Shares covered by such Award, the Company shall not be required to sell or issue
such Shares unless the Board has received evidence satisfactory to it that the Grantee or any other individual exercising an Option may
acquire such Shares pursuant to an exemption from registration under the Securities Act. The Company may, but shall in no event be obligated
to, register any securities covered hereby pursuant to the Securities Act. The Company shall not be obligated to take any affirmative
action in order to cause the exercise of an Inducement Non-Qualified Stock Option Award or the issuance of Shares pursuant to the Plan
to comply with any law or regulation of any governmental authority. As to any jurisdiction that expressly imposes the requirement that
an Inducement Non-Qualified Stock Option Award shall not be exercisable until the Shares covered by such Inducement Non-Qualified Stock
Option Award are registered or are exempt from registration, the exercise of such Inducement Non-Qualified Stock Option Award (under circumstances
in which the laws of such jurisdiction apply) shall be deemed conditioned upon the effectiveness of such registration or the availability
of such an exemption.

 

    6

     

    

 

9.2. Rule 16b-3

 

During any time when the Company has a class of
equity security registered under Section 12 of the Exchange Act, it is the intent of the Company that Awards and the exercise of
Inducement Non-Qualified Stock Option Awards granted hereunder will qualify for the exemption provided by Rule 16b-3 under the Exchange
Act. To the extent that any provision of the Plan or action by the Board does not comply with the requirements of Rule 16b-3, it shall
be deemed inoperative to the extent permitted by law and deemed advisable by the Board, and shall not affect the validity of the Plan.
In the event that Rule 16b-3 is revised or replaced, the Board may modify the Plan in any respect necessary to satisfy the requirements
of, or to take advantage of any features of, the revised exemption or its replacement.

 

		10.	EFFECT OF CHANGES IN CAPITALIZATION

 

10.1. Adjustments
for Changes in Capital Structure

 

Subject to any required action by the Company’s
stockholders, in the event of any change in the Common Stock effected without receipt of consideration by the Company, whether through
merger, consolidation, reorganization, reincorporation, recapitalization, reclassification, stock dividend, stock split, reverse stock
split, split-up, split-off, spin-off, combination of shares, exchange of shares or similar change in the capital structure of the Company,
or in the event of payment of a dividend or distribution to the Company’s stockholders in a form other than Shares (excepting normal
cash dividends) that has a material effect on the Fair Market Value, appropriate and proportionate adjustments shall be made in the number
and class of shares subject to the Plan and to any outstanding Awards, and in the Option Price, SAR Exercise Price or Purchase Price per
Share of any outstanding Awards in order to prevent dilution or enlargement of Grantees’ rights under the Plan. For purposes of
the foregoing, conversion of any convertible securities of the Company shall not be treated as “effected without receipt of consideration
by the Company.” If a majority of the Shares which are of the same class as the Shares that are subject to outstanding Awards are
exchanged for, converted into, or otherwise become (whether or not pursuant to a Change in Control) shares of another corporation (the
“New Shares”), the Board may unilaterally amend the outstanding Awards to provide that such Awards are for New Shares. In
the event of any such amendment, the number of Shares subject to, and the Option Price of the outstanding Awards shall be adjusted in
a fair and equitable manner. Any fractional share resulting from an adjustment pursuant to this Section 10.1 shall be rounded
down to the nearest whole number and the Option Pric per share shall be rounded up to the nearest whole cent. In no event may the exercise
price of any Award be decreased to an amount less than the par value, if any, of the stock subject to the Award. The Board may also make
such adjustments in the terms of any Award to reflect, or related to, such changes in the capital structure of the Company or distributions
as it deems appropriate. Adjustments determined by the Board pursuant to this Section 14.1 shall be made in accordance
with Section 409A to the extent applicable.

 

    7

     

    

 

10.2. Change
in Control

 

10.2.1. Consequences
of a Change in Control

 

Unless otherwise provided in the applicable Award
Agreement, either of the following provisions shall apply, depending on whether, and the extent to which, such Awards are assumed, converted
or replaced by the resulting entity in a Change in Control:

 

		(i)	To the extent such Awards are not assumed, converted or replaced by the resulting entity in the Change in Control, then upon the Change
in Control such outstanding Awards that may be exercised shall become fully exercisable, and all restrictions with respect to such outstanding
Awards shall lapse and become vested and non-forfeitable.

 

		(ii)	To the extent such Awards are assumed, converted or replaced by the resulting entity in the Change in Control, if, within two years
after the date of the Change in Control, the Grantee has a Separation from Service either (1) by the Company other than for Cause or (2)
by the Grantee for “good reason” (as defined in the applicable Award Agreement), then such outstanding Awards that may be
exercised shall become fully exercisable, and all restrictions with respect to such outstanding Awards shall lapse and become vested and
non-forfeitable.

 

10.2.2. Change
in Control Defined

 

Unless otherwise provided in the applicable Award
Agreement, a “Change in Control” means the consummation of any of the following events:

 

		(i)	The acquisition, other than from the Company, by any individual, entity or group (within the meaning of Section 13(d)(3) or Section 14(d)(2)
of the Exchange Act), other than the Company or any subsidiary, affiliate (within the meaning of Rule 144 promulgated under the Securities
Act) or employee benefit plan of the Company, of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange
Act) of more than 50% of the combined voting power of the then outstanding voting securities of the Company entitled to vote generally
in the election of directors (the “Voting Securities”); or

 

		(ii)	A reorganization, merger, consolidation or recapitalization of the Company (a “Business Combination”), other than
a Business Combination in which more than 50% of the combined voting power of the outstanding voting securities of the surviving or resulting
entity immediately following the Business Combination is held by the Persons who, immediately prior to the Business Combination, were
the holders of the Voting Securities; or

 

		(iii)	A complete liquidation or dissolution of the Company, or a sale of all or substantially all of the assets of the Company; or

 

		(iv)	During any period of 24 consecutive months, the Incumbent Directors cease to constitute a majority of the Board; “Incumbent
Directors” means individuals who were members of the Board at the beginning of such period or individuals whose election or
nomination for election to the Board by the stockholders of the Company was approved by a vote of at least a majority of the then Incumbent
Directors (but excluding any individual whose initial election or nomination is in connection with an actual or threatened proxy contest
relating to the election of directors).

 

    8

     

    

 

Notwithstanding the foregoing, if it is determined
that an Award is subject to the requirements of Section 409A and payable upon a Change in Control, the Company will not be deemed
to have undergone a Change in Control for purposes of the Plan unless the Company is deemed to have undergone a “change in control
event” pursuant to the definition of such term in Section 409A.

 

10.3. Adjustments

 

Adjustments under this Section 10 related
to Shares or securities of the Company shall be made by the Board. No fractional shares or other securities shall be issued pursuant to
any such adjustment, and any fractions resulting from any such adjustment shall be eliminated in each case by rounding downward to the
nearest whole share.

 

		11.	No Limitations on Company

 

The making of Awards pursuant to the Plan shall
not affect or limit in any way the right or power of the Company to make adjustments, reclassifications, reorganizations, or changes of
its capital or business structure or to merge, consolidate, dissolve, or liquidate, or to sell or transfer all or any part of its business
or assets.

 

		12.	TERMS APPLICABLE GENERALLY TO AWARDS GRANTED UNDER THE PLAN

 

12.1. Disclaimer
of Rights

 

No provision in the Plan or in any Award Agreement
shall be construed to confer upon any individual the right to remain in the employ or service of the Company or any Affiliate, or to interfere
in any way with any contractual or other right or authority of the Company either to increase or decrease the compensation or other payments
to any individual at any time, or to terminate any employment or other relationship between any individual and the Company. In addition,
notwithstanding anything contained in the Plan to the contrary, unless otherwise stated in the applicable Award Agreement, no Award granted
under the Plan shall be affected by any change of duties or position of the Grantee, so long as such Grantee continues to be an employee.
The obligation of the Company to pay any benefits pursuant to this Plan shall be interpreted as a contractual obligation to pay only those
amounts described herein, in the manner and under the conditions prescribed herein. The Plan shall in no way be interpreted to require
the Company to transfer any amounts to a third party trustee or otherwise hold any amounts in trust or escrow for payment to any Grantee
or beneficiary under the terms of the Plan.

 

12.2. Withholding
Taxes

 

The Company or an Affiliate, as the case may be,
shall have the right to deduct from payments of any kind otherwise due to a Grantee any federal, state, or local taxes of any kind required
by law to be withheld (i) with respect to the vesting of or other lapse of restrictions applicable to an Award, (ii) upon the
issuance of Shares upon the exercise of an Inducement Non-Qualified Stock Option Award, or (iii) otherwise due in connection with
an Award. At the time of such vesting, lapse, or exercise, the Grantee shall pay to the Company or the Affiliate, as the case may be,
any amount that the Company or the Affiliate may reasonably determine to be necessary to satisfy such withholding obligation. Subject
to the prior approval of the Board, the Grantee may elect to satisfy such obligations, in whole or in part, (i) by causing the Company
or the Affiliate to withhold the minimum required number of Shares otherwise issuable to the Grantee as may be necessary to satisfy such
withholding obligation or (ii) by delivering to the Company or the Affiliate Shares already owned by the Grantee. The Shares so delivered
or withheld shall have an aggregate Fair Market Value equal to such withholding obligations. The Fair Market Value used to satisfy such
withholding obligation shall be determined by the Company or the Affiliate as of the date that the amount of tax to be withheld is to
be determined. A Grantee who has made an election pursuant to this Section 12.2 may satisfy his or her withholding obligation only
with Shares that are not subject to any repurchase, forfeiture, unfulfilled vesting, or other similar requirements.

 

    9

     

    

 

12.3. Other
Provisions

 

Each Award Agreement
may contain such other terms and conditions not inconsistent with the Plan as may be determined by the Board,
in its sole discretion. 

 

12.4. Market
Standoff Requirement

 

Unless otherwise provided in the applicable Award
Agreement or other agreement to which a Grantee is a party, in connection with any underwritten public offering of its Common Stock (“Offering”)
and upon request of the Company or the underwriters managing the Offering, Grantees shall not be permitted to sell, make any short sale
of, loan, grant any option for the purchase of or otherwise directly or indirectly dispose of any Common Stock delivered under the Plan
(other than those Shares included in the Offering) without the prior written consent of the Company or such underwriters, as the case
may be, for such period of time from the effective date of the registration statement with respect to such Offering as may be requested
by the Company or such managing underwriters and to execute an agreement reflecting the foregoing as may be requested by the underwriters
in connection with such Offering.

 

12.5. Severability

 

If any provision of the Plan or any Award Agreement
shall be determined to be illegal or unenforceable by any court of law in any jurisdiction, the remaining provisions hereof and thereof
shall be severable and enforceable in accordance with their terms, and all provisions shall remain enforceable in any other jurisdiction.

 

12.6. Governing
Law

 

The Plan shall be governed by and construed in
accordance with the laws of the State of Delaware without giving effect to the principles of conflicts of law, and applicable Federal
law.

 

12.7. Section 409A

 

The Plan is intended to comply with Section 409A
to the extent subject thereto, and, accordingly, to the maximum extent permitted, the Plan shall be interpreted and administered to be
in compliance therewith. Any payments described in the Plan that are due within the “short-term deferral period” as defined
in Section 409A shall not be treated as deferred compensation unless applicable laws require otherwise. Notwithstanding anything
to the contrary in the Plan, to the extent required to avoid accelerated taxation and tax penalties under Section 409A, amounts that
would otherwise be payable and benefits that would otherwise be provided pursuant to the Plan during the six-month period immediately
following the Grantee’s Separation from Service shall instead be paid on the first payroll date after the six-month anniversary
of the Grantee’s Separation from Service (or the Grantee’s death, if earlier). Notwithstanding the foregoing, neither the
Company nor the Board shall have any obligation to take any action to prevent the assessment of any excise tax or penalty on any Grantee
under Section 409A and neither the Company nor the Board shall have any liability to any Grantee for such tax or penalty.

 

    10

     

    

 

12.8. Separation
from Service

 

The Board
shall determine the effect of a Separation from Service upon Awards, and such effect shall be set forth
in the appropriate Award Agreement. Without limiting the foregoing, the Board may provide in the
Award Agreements at the time of grant, or any time thereafter with the consent of the Grantee, the actions that will be taken upon the
occurrence of a Separation from Service, including, but not limited to, accelerated vesting or termination, depending upon the circumstances
surrounding the Separation from Service.

 

12.9. Transferability
of Awards

 

12.9.1.
Transfers in General

 

Except as provided in Section 12.9.2, no Award
shall be assignable or transferable by the Grantee to whom it is granted, other than by will or the laws of descent and distribution,
and, during the lifetime of the Grantee, only the Grantee personally (or the Grantee’s personal representative) may exercise rights
under the Plan.

 

12.9.2.
Family Transfers

 

If authorized in the applicable Award Agreement,
a Grantee may transfer, not for value, all or part of an Award to any Family Member. For the purpose of this Section 12.9.2, a
“not for value” transfer is a transfer which is (i) a gift, (ii) a transfer under a domestic relations order in
settlement of marital property rights; or (iii) a transfer to an entity in which more than fifty percent of the voting interests
are owned by Family Members (or the Grantee) in exchange for an interest in that entity. Following a transfer under this Section 12.9.2,
any such Award shall continue to be subject to the same terms and conditions as were applicable immediately prior to transfer. Subsequent
transfers of transferred Awards are prohibited except to Family Members of the original Grantee in accordance with this Section 12.9.2
or by will or the laws of descent and distribution.

 

12.10. Dividends
and Dividend Equivalent Rights

 

If specified in the Award Agreement, the recipient
of an Award under this Plan may be entitled to receive, currently or on a deferred basis, dividends or dividend equivalents with respect
to the Shares or other securities covered by an Award. The terms and conditions of a dividend equivalent right may be set forth in the
Award Agreement. Dividend equivalents credited to a Grantee may be paid currently or may be deemed to be reinvested in additional Shares
or other securities of the Company at a price per unit equal to the Fair Market Value of a Share on the date that such dividend was paid
to stockholders, as determined in the sole discretion of the Board.

 

12.11. Plan
Construction

 

In the Plan, unless otherwise stated, the following
uses apply: (i) references to a statute or law refer to the statute or law and any amendments and any successor statutes or laws,
and to all valid and binding governmental regulations, court decisions and other regulatory and judicial authority issued or rendered
thereunder, as amended, or their successors, as in effect at the relevant time; (ii) in computing periods from a specified date to
a later specified date, the words “from” and “commencing on” (and the like) mean “from and including,”
and the words “to,” “until” and “ending on” (and the like) mean “to and including”; (iii) indications
of time of day shall be based upon the time applicable to the location of the principal headquarters of the Company; (iv) the words
“include,” “includes” and “including” (and the like) mean “include, without limitation,”
“includes, without limitation” and “including, without limitation” (and the like), respectively; (v) all
references to articles and sections are to articles and sections in the Plan; (vi) all words used shall be construed to be of such
gender or number as the circumstances and context require; (vii) the captions and headings of articles and sections have been inserted
solely for convenience of reference and shall not be considered a part of the Plan, nor shall any of them affect the meaning or interpretation
of the Plan or any of its provisions; (viii) any reference to an agreement, plan, policy, form, document or set of documents, and
the rights and obligations of the parties under any such agreement, plan, policy, form, document or set of documents, shall mean such
agreement, plan, policy, form, document or set of documents as amended from time to time, and any and all modifications, extensions, renewals,
substitutions or replacements thereof; and (ix) all accounting terms not specifically defined shall be construed in accordance with
generally accepted accounting principles.

 

* * *

 

The Plan was adopted by the Board of Directors of the Company on September
15, 2021.

 

 

11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}]]